Skip to content

Theriva Biologics, Inc.: filings

Every Theriva Biologics, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 62 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-11fiscal Q2 2026401140001104659-26-093786
10-Q2026-05-05fiscal Q1 202638800001104659-26-055689
10-K2026-03-12fiscal FY 202542860001104659-26-026767
10-Q2025-11-12fiscal Q3 2025401170001104659-25-109828
10-Q2025-08-11fiscal Q2 2025391110001410578-25-001654
10-Q2025-05-14fiscal Q1 202536770001410578-25-001242
10-K2025-03-06fiscal FY 202444890001410578-25-000285
10-Q2024-11-12fiscal Q3 2024411190001410578-24-001850
10-Q2024-08-13fiscal Q2 2024401120001410578-24-001342
10-Q2024-05-07fiscal Q1 202440800001410578-24-000601
10-K2024-03-25fiscal FY 202347940001410578-24-000293
10-Q2023-11-13fiscal Q3 2023441270001410578-23-002348
10-Q2023-08-08fiscal Q2 2023421190001410578-23-001584
10-Q2023-05-11fiscal Q1 202342890001410578-23-000987
10-K2023-03-30fiscal FY 2022472020001410578-23-000428
10-Q2022-11-10fiscal Q3 2022441270001410578-22-003167
10-Q2022-08-11fiscal Q2 2022441220001410578-22-002238
10-Q2022-05-16fiscal Q1 202244870001410578-22-001679
10-K2022-03-16fiscal FY 202141820001410578-22-000405
10-Q2021-11-03fiscal Q3 2021381130001104659-21-133722
10-Q2021-08-05fiscal Q2 202134930001104659-21-100800
10-Q2021-05-05fiscal Q1 202134720001104659-21-061771
10-K2021-03-04fiscal FY 202034700001104659-21-032150
10-Q2020-11-10fiscal Q3 202033950001104659-20-123646
10-Q2020-08-06fiscal Q2 202032890001104659-20-091503
10-Q2020-05-05fiscal Q1 202032670001104659-20-056927
10-K2020-02-20fiscal FY 201934710001104659-20-023415
10-Q2019-11-04fiscal Q3 2019371090001104659-19-059538
10-Q2019-08-08fiscal Q2 2019371050001144204-19-038590
10-Q2019-05-08fiscal Q1 201937770001144204-19-024539
10-K2019-02-27fiscal FY 2018361130001144204-19-010592
10-Q2018-11-08fiscal Q3 201834960001144204-18-058414
10-Q2018-08-08fiscal Q2 201834940001144204-18-042887
10-Q2018-05-08fiscal Q1 201834700001144204-18-026171
10-K2018-02-22fiscal FY 2017371330001144204-18-010286
10-Q2017-11-01fiscal Q3 201734940001144204-17-055540
10-Q2017-08-03fiscal Q2 201734940001144204-17-040110
10-Q2017-05-04fiscal Q1 201734700001144204-17-024592
10-K2017-03-02fiscal FY 2016371320001144204-17-012545
10-Q2016-11-01fiscal Q3 201632900001144204-16-130708
10-Q2016-08-03fiscal Q2 201631880001144204-16-116282
10-Q2016-05-05fiscal Q1 201626540001144204-16-099287
10-K2016-03-10fiscal FY 2015371160001144204-16-087267
10-Q2015-11-05fiscal Q3 2015361000001144204-15-063126
10-Q2015-08-10fiscal Q2 201530780001144204-15-047629
10-Q2015-05-11fiscal Q1 201529600001144204-15-029365
10-K2015-03-16fiscal FY 2014351050001144204-15-016433
10-Q2014-11-14fiscal Q3 201427720001144204-14-068250
10-Q2014-08-14fiscal Q2 201426700001144204-14-049974
10-Q2014-05-15fiscal Q1 201427560001144204-14-031292
10-K2014-03-31fiscal FY 201334690001144204-14-019505
10-Q2013-11-14fiscal Q3 201327680001144204-13-061598
10-Q2013-08-14fiscal Q2 201329720001144204-13-045994
10-Q2013-05-15fiscal Q1 201327540001144204-13-029231
10-K2013-04-16fiscal FY 201232640001144204-13-022048
10-Q2012-11-14fiscal Q3 201229710001144204-12-062658
10-Q/A2012-09-11fiscal Q2 201227660001144204-12-050690
10-Q2012-05-15fiscal Q1 201224480001144204-12-029753
10-K/A2012-05-11fiscal FY 201126530001144204-12-028166
10-K2012-03-30fiscal FY 201126530001144204-12-018627
10-Q2011-11-14fiscal Q3 201128700001144204-11-064312
10-Q2011-08-15fiscal Q2 201132860001144204-11-047255

Inspect the source

Entity
Theriva Biologics, Inc. / CIK 0000894158
Captured
SEC response SHA-256
0de75e0c14bf762eac1125a82293caea25684675d03e66311f5d17f900dbb0a7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

The MCP server is free and MIT-licensed: npx -y canli-mcp. If these records help your research, a star on GitHub helps other researchers find them.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000894158.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))